Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020			$ 8,570	$ 102,729,944	$ 2,143,338	$ (44,910,297)	$ 59,971,555	$ 38,023,260	$ 97,994,815
Beginning balance, shares at Dec. 31, 2020			8,570,000
Beneficial Conversion Feature Intrinsic Value, Net				50,770,192			50,770,192		50,770,192
Change in Non-Controlling Interest				76,412	(39,067)		37,345	(37,345)
Change in Unrealized Gain (Loss) on Investment					(1,135)		(1,135)	(852)	(1,987)
Foreign Currency Translations					(1,010,527)		(1,010,527)	(758,913)	(1,769,440)
Net Loss						(6,238,449)	(6,238,449)	(3,569,112)	(9,807,561)
Issuance of Stock for Services			$ 10	60,890			60,900		60,900
Issuance of Stock for Services, shares			10,000
Transactions under Common Control				(57,190,499)			(57,190,499)		(57,190,499)
Sale of Vivacitas to Related Party				2,279,872			2,279,872		2,279,872
Purchase Stock of True Partner from Related Party				3,274,060			3,274,060		3,274,060
Subsidiary's Issuance of Stock				46,099			46,099	34,677	80,776
Proceeds from Selling Subsidiary Equity				142,675.00			142,675	107,325	250,000
Distribution to Non-Controlling Shareholders								(82,250)	(82,250)
Ending balance, value at Mar. 31, 2021			$ 8,580	102,189,645	1,092,609	(51,148,746)	52,142,088	33,716,790	85,858,878
Ending balance, shares at Mar. 31, 2021			8,580,000
Beginning balance, value at Dec. 31, 2020			$ 8,570	102,729,944	2,143,338	(44,910,297)	59,971,555	38,023,260	97,994,815
Beginning balance, shares at Dec. 31, 2020			8,570,000
Net Loss									(92,771,369)
Ending balance, value at Sep. 30, 2021			$ 45,722	266,633,480	(1,002,212)	(124,909,747)	140,767,243	25,139,975	165,907,218
Ending balance, shares at Sep. 30, 2021			45,721,779
Beginning balance, value at Mar. 31, 2021			$ 8,580	102,189,645	1,092,609	(51,148,746)	52,142,088	33,716,790	85,858,878
Beginning balance, shares at Mar. 31, 2021			8,580,000
Change in Non-Controlling Interest				(2,885,117)	(343,225)		(3,228,342)	3,228,342
Change in Unrealized Gain (Loss) on Investment					(25,663)		(25,663)	(10,259)	(35,922)
Foreign Currency Translations					(764,544)		(764,544)	(305,647)	(1,070,191)
Net Loss						(66,650,864)	(66,650,864)	(8,238,460)	(74,889,324)
Issuance of Common Stock			$ 8,389	39,260,191			39,268,580		39,268,580
Issuance of Common Stock, shares			8,389,324
Proceeds from Selling Subsidiary Equity				21,432			21,432	8,568	30,000
Distribution to Non-Controlling Shareholders								(1,069,250)	(1,069,250)
Change Common stock to Series A Preferred Stock	$ 6		$ (6,380)	6,374
Change Common stock to Series A Preferred Stock, shares	6,380		(6,380,000)
Issuance of Series B Preferred Stock		$ 2		12,999,998			13,000,000		13,000,000
Issuance of Series B Preferred Stock, shares		2,132
Convert Preferred Stock Series A and B to Common	$ (6)	$ (2)	$ 8,512	(8,503)
Convert Preferred Stock Series A and B to Common, shares	(6,380)	(2,132)	8,512,000
Convertible Note to Stock			$ 9,164	51,217,402			51,226,566		51,226,566
Convertible Note to Stock, shares			9,163,965
Subsidiary's Issuance of Stock				1,961,349			1,961,349	784,100	2,745,449
Ending balance, value at Jun. 30, 2021			$ 28,265	204,762,770	(40,823)	(117,799,610)	86,950,602	28,114,184	115,064,786
Ending balance, shares at Jun. 30, 2021			28,265,289
Change in Non-Controlling Interest				(910,067)	(17,070)		(927,137)	(1,272,853)	(2,199,990)
Change in Unrealized Gain (Loss) on Investment					(14,314)		(14,314)	(4,746)	(19,060)
Foreign Currency Translations					(930,005)		(930,005)	(308,351)	(1,238,356)
Net Loss						(7,110,137)	(7,110,137)	(964,347)	(8,074,484)
Issuance of Common Stock			$ 17,457	33,871,847			33,889,304		33,889,304
Issuance of Common Stock, shares			17,456,490
Distribution to Non-Controlling Shareholders								(246,750)	(246,750)
Subsidiary's Issuance of Stock				166,655			166,655	55,256	221,911
Deconsolidate American Pacific Bancorp Inc.				28,287,920			28,287,920	(383,063)	27,904,857
Exercise American Premium Water Corp. Warrant to Purchase Stock				454,355			454,355	150,645	605,000
Ending balance, value at Sep. 30, 2021			$ 45,722	266,633,480	(1,002,212)	(124,909,747)	140,767,243	25,139,975	165,907,218
Ending balance, shares at Sep. 30, 2021			45,721,779
Beginning balance, value at Dec. 31, 2021			$ 87,368	296,181,977	341,646	(148,233,473)	148,377,518	21,912,268	170,289,786
Beginning balance, shares at Dec. 31, 2021			87,368,446
Issuance of Stock by Exercising Warrants			$ 15,820	(11,925)			3,895		3,895
Issuance of Stock by Exercising Warrants, shares			15,819,452
Convert Related Party Note to Common Stock			$ 10,000	6,203,000			6,213,000		6,213,000
Convert Related Party Note to Common Stock, shares			10,000,000
Deconsolidate Alset Capital Acquisition				17,160,800			17,160,800	2,227,744	19,388,544
Gain from Purchase of DSS Stock				737,572			737,572		737,572
Beneficial Conversion Feature Intrinsic Value, Net				450,000			450,000		450,000
Change in Non-Controlling Interest				(316,459)	459,069		142,610	(142,610)
Change in Unrealized Gain (Loss) on Investment					(7,027)		(7,027)	(2,096)	(9,123)
Foreign Currency Translations					(499,967)		(499,967)	(149,173)	(649,140)
Net Loss						(6,467,286)	(6,467,286)	(1,463,167)	(7,930,453)
Ending balance, value at Mar. 31, 2022			$ 113,188	320,404,965	293,721	(154,700,759)	166,111,115	22,382,966	188,494,081
Ending balance, shares at Mar. 31, 2022			113,187,898
Beginning balance, value at Dec. 31, 2021			$ 87,368	296,181,977	341,646	(148,233,473)	148,377,518	21,912,268	170,289,786
Beginning balance, shares at Dec. 31, 2021			87,368,446
Net Loss									(30,994,705)
Distribution to Non-Controlling Shareholders									(1,398,250)
Ending balance, value at Sep. 30, 2022			$ 148,507	322,318,500	485,331	(175,407,945)	147,544,393	12,015,513	159,559,906
Ending balance, shares at Sep. 30, 2022			148,507,188
Beginning balance, value at Mar. 31, 2022			$ 113,188	320,404,965	293,721	(154,700,759)	166,111,115	22,382,966	188,494,081
Beginning balance, shares at Mar. 31, 2022			113,187,898
Change in Non-Controlling Interest				4,557,454	3,266,996		7,824,450	(7,824,450)
Change in Unrealized Gain (Loss) on Investment					(505)		(505)	(86)	(591)
Foreign Currency Translations					(3,002,167)		(3,002,167)	(512,428)	(3,514,595)
Net Loss						(8,987,359)	(8,987,359)	(995,502)	(9,982,861)
Issuance of Common Stock			$ 35,319	(35,319)
Issuance of Common Stock, shares			35,319,290
Change in Valuation on Investment				(2,624,585)			(2,624,585)	(206,377)	(2,830,962)
Ending balance, value at Jun. 30, 2022			$ 148,507	322,302,515	558,045	(163,688,118)	159,320,949	12,844,123	172,165,072
Ending balance, shares at Jun. 30, 2022			148,507,188
Change in Non-Controlling Interest				15,985	(486,134)		(470,149)	470,149
Change in Unrealized Gain (Loss) on Investment					42,642		42,642	7,273	49,915
Foreign Currency Translations					370,778		370,778	63,233	434,011
Net Loss						(11,719,827)	(11,719,827)	(1,369,265)	(13,089,092)
Ending balance, value at Sep. 30, 2022			$ 148,507	$ 322,318,500	$ 485,331	$ (175,407,945)	$ 147,544,393	$ 12,015,513	$ 159,559,906
Ending balance, shares at Sep. 30, 2022			148,507,188